{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:28:21Z","timestamp":1783488501076,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,28]]},"DOI":"10.7759\/cureus.46134","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T15:11:41Z","timestamp":1695913901000},"source":"Crossref","is-referenced-by-count":8,"title":["The Relationship Between Myocardial Infarction and Estrogen Use: A Literature Review"],"prefix":"10.7759","author":[{"given":"Ayesha","family":"Javed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phanish C","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bilal Delvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqra","family":"Faraz Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo J","family":"Acosta G.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warda","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vamsi","family":"Krishnamaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saya","family":"Alasaadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetapadma","family":"Pradhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishabh","family":"Vashisht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivani","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e3283431921","article-title":"Estrogen, hormonal replacement therapy and cardiovascular disease","volume":"20","author":"Yang XP","year":"2011","unstructured":"Yang XP, Reckelhoff JF. Estrogen, hormonal replacement therapy and cardiovascular disease. Curr Opin Nephrol Hypertens. 2011, 20:133-8. 10.1097\/MNH.0b013e3283431921","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI125755","article-title":"Impact of estrogens in males and androgens in females","volume":"129","author":"Hammes SR","year":"2019","unstructured":"Hammes SR, Levin ER. Impact of estrogens in males and androgens in females. J Clin Invest. 2019, 129:1818-26. 10.1172\/JCI125755","journal-title":"J Clin Invest"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9349","article-title":"Global epidemiology of ischemic heart disease: results from the Global Burden of Disease Study","volume":"12","author":"Khan MA","year":"2020","unstructured":"Khan MA, Hashim MJ, Mustafa H, et al.. Global epidemiology of ischemic heart disease: results from the Global Burden of Disease Study. Cureus. 2020, 12:e9349. 10.7759\/cureus.9349","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s12872-023-03231-w","article-title":"The global prevalence of myocardial infarction: a systematic review and meta-analysis","volume":"23","author":"Salari N","year":"2023","unstructured":"Salari N, Morddarvanjoghi F, Abdolmaleki A, et al.. The global prevalence of myocardial infarction: a systematic review and meta-analysis. BMC Cardiovasc Disord. 2023, 23:206. 10.1186\/s12872-023-03231-w","journal-title":"BMC Cardiovasc Disord"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.6.5765-4","article-title":"The epidemiology of cardiovascular disease in postmenopausal women","volume":"84","author":"Sybil LC","year":"1999","unstructured":"Sybil LC, Johannes CB. The epidemiology of cardiovascular disease in postmenopausal women.  J Clin Endocrinol Metab. 1999, 84:1803-12. 10.1210\/jcem.84.6.5765-4","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpcardiol.2009.10.002","article-title":"Growing epidemic of coronary heart disease in low- and middle-income countries","volume":"35","author":"Gaziano TA","year":"2010","unstructured":"Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low- and middle-income countries. Curr Probl Cardiol. 2010, 35:72-115. 10.1016\/j.cpcardiol.2009.10.002","journal-title":"Curr Probl Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1112570","article-title":"A tale of coronary artery disease and myocardial infarction","volume":"366","author":"Nabel EG","year":"2012","unstructured":"Nabel EG, Braunwald E. A tale of coronary artery disease and myocardial infarction. N Engl J Med. 2012, 366:54-63. 10.1056\/NEJMra1112570","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1136\/hrt.2008.153387","article-title":"Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes. The global registry of acute coronary events","volume":"95","author":"Brieger D","year":"2009","unstructured":"Brieger D, Fox KAA, FitzGerald G, et al.. Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes. The global registry of acute coronary events. Heart. 2009, 95:888-94.","journal-title":"Heart"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.05.008","article-title":"Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention","volume":"56","author":"Roe MT","year":"2010","unstructured":"Roe MT, Messenger JC, Weintraub WS, et al.. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol. 2010, 56:254-63. 10.1016\/j.jacc.2010.05.008","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1012848","article-title":"Lifetime risks of cardiovascular disease","volume":"366","author":"Berry JD","year":"2012","unstructured":"Berry JD, Dyer A, Cai X, et al.. Lifetime risks of cardiovascular disease. N Engl J Med. 2012, 366:321-9. 10.1056\/NEJMoa1012848","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/1076029610368670","article-title":"Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use","volume":"17","author":"Zakharova MY","year":"2011","unstructured":"Zakharova MY, Meyer RM, Brandy KR, et al.. Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use. Clin Appl Thromb Hemost. 2011, 17:323-31. 10.1177\/1076029610368670","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.7.605","article-title":"Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group","volume":"280","author":"Hulley S","year":"1998","unstructured":"Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen\/progestin Replacement Study (HERS) Research Group. JAMA. 1998, 280:605-13. 10.1001\/jama.280.7.605","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.1.49","article-title":"Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow-up (HERS II)","volume":"288","author":"Grady D","year":"2002","unstructured":"Grady D, Herrington D, Bittner V, et al.. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen\/progestin Replacement Study follow-up (HERS II). JAMA. 2002, 288:49-57. 10.1001\/jama.288.1.49","journal-title":"JAMA"},{"key":"ref14","article-title":"","author":"Delgado BJ","year":"2023","unstructured":"Delgado BJ, Lopez-Ojeda W. Estrogen. StatPearls Publishing, Treasure Island, FL; 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538260\/."},{"key":"ref15","article-title":"Hormone replacement therapy","author":"Harper-Harrison G","year":"2023","unstructured":"Harper-Harrison G, Shanahan MM. Hormone replacement therapy. StatPearls, Treasure Island, FL; 2023."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0b013e31829a64f9","article-title":"Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study","volume":"21","author":"Shufelt CL","year":"2014","unstructured":"Shufelt CL, Merz CN, Prentice RL, et al.. Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study. Menopause. 2014, 21:260-6. 10.1097\/GME.0b013e31829a64f9","journal-title":"Menopause"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00588.2009","article-title":"A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury","volume":"298","author":"Bopassa JC","year":"2010","unstructured":"Bopassa JC, Eghbali M, Toro L, Stefani E. A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2010, 298:H16-23. 10.1152\/ajpheart.00588.2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000105682.85732.BD","article-title":"17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine\/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway","volume":"109","author":"Babiker FA","year":"2004","unstructured":"Babiker FA, De Windt LJ, van Eickels M, et al.. 17beta-estradiol antagonizes cardiomyocyte hypertrophy by autocrine\/paracrine stimulation of a guanylyl cyclase A receptor-cyclic guanosine monophosphate-dependent protein kinase pathway. Circulation. 2004, 109:269-76. 10.1161\/01.CIR.0000105682.85732.BD","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.109.213645","article-title":"Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females","volume":"106","author":"Lagranha CJ","year":"2010","unstructured":"Lagranha CJ, Deschamps A, Aponte A, Steenbergen C, Murphy E. Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ Res. 2010, 106:1681-91. 10.1161\/CIRCRESAHA.109.213645","journal-title":"Circ Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13293-017-0152-8","article-title":"The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy","volume":"8","author":"Iorga A","year":"2017","unstructured":"Iorga A, Cunningham CM, Moazeni S, Ruffenach G, Umar S, Eghbali M. The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy. Biol Sex Differ. 2017, 8:33. 10.1186\/s13293-017-0152-8","journal-title":"Biol Sex Differ"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1530\/JME-13-0021","article-title":"G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection","volume":"51","author":"Lenhart PM","year":"2013","unstructured":"Lenhart PM, Broselid S, Barrick CJ, Leeb-Lundberg LM, Caron KM. G-protein-coupled receptor 30 interacts with receptor activity-modifying protein 3 and confers sex-dependent cardioprotection. J Mol Endocrinol. 2013, 51:191-202. 10.1530\/JME-13-0021","journal-title":"J Mol Endocrinol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of the North American Menopause Society","volume":"29","author":"Chrisandra L. Shufelt","year":"2022","unstructured":"Chrisandra L. Shufelt, Vivien Brown, Janet S. The 2022 hormone therapy position statement of the North American Menopause Society. Menopause. 2022, 29:767-94. 10.1097\/GME.0000000000002028","journal-title":"Menopause"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5523516","article-title":"Protective effects of estrogen on cardiovascular disease mediated by oxidative stress","volume":"2021","author":"Xiang D","year":"2021","unstructured":"Xiang D, Liu Y, Zhou S, Zhou E, Wang Y. Protective effects of estrogen on cardiovascular disease mediated by oxidative stress. Oxid Med Cell Longev. 2021, 2021:5523516. 10.1155\/2021\/5523516","journal-title":"Oxid Med Cell Longev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1505241","article-title":"Vascular effects of early versus late postmenopausal treatment with estradiol","volume":"374","author":"Hodis HN","year":"2016","unstructured":"Hodis HN, Mack WJ, Henderson VW, et al.. Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med. 2016, 374:1221-31. 10.1056\/NEJMoa1505241","journal-title":"N Engl J Med"},{"key":"ref25","article-title":"Assessing benefits and risks of hormone therapy in 2008: new evidence, especially with regard to the heart","volume":"75","author":"Holly LT","year":"2008","unstructured":"Holly LT,  Hodis NH. Assessing benefits and risks of hormone therapy in 2008: new evidence, especially with regard to the heart. Cleve Clin J Med. 2008, 75:3.","journal-title":"Cleve Clin J Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.4161\/epi.6.6.16177","article-title":"The epigenetics of estrogen: epigenetic regulation of hormone-induced memory enhancement","volume":"6","author":"Frick KM","year":"2011","unstructured":"Frick KM, Zhao Z, Fan L. The epigenetics of estrogen: epigenetic regulation of hormone-induced memory enhancement. Epigenetics. 2011, 6:675-80. 10.4161\/epi.6.6.16177","journal-title":"Epigenetics"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-023-02757-2","article-title":"Associations of reproductive factors with incidence of myocardial infarction and ischemic stroke in postmenopausal women: a cohort study","volume":"21","author":"Jeong SM","year":"2023","unstructured":"Jeong SM, Yoo JE, Jeon KH, Han K, Lee H, Lee DY, Shin DW. Associations of reproductive factors with incidence of myocardial infarction and ischemic stroke in postmenopausal women: a cohort study. BMC Med. 2023, 21:64. 10.1186\/s12916-023-02757-2","journal-title":"BMC Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X15666190729153026","article-title":"Estrogen deprivation and myocardial infarction: role of aerobic exercise training, inflammation and metabolomics","volume":"16","author":"Ruberti OM","year":"2020","unstructured":"Ruberti OM, Rodrigues B. Estrogen deprivation and myocardial infarction: role of aerobic exercise training, inflammation and metabolomics. Curr Cardiol Rev. 2020, 16:292-305. 10.2174\/1573403X15666190729153026","journal-title":"Curr Cardiol Rev"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s0010-7824(97)00029-2","article-title":"Estrogen and progestin components of oral contraceptives: relationship to vascular disease","volume":"55","author":"Carr BR","year":"1997","unstructured":"Carr BR, Ory H. Estrogen and progestin components of oral contraceptives: relationship to vascular disease. Int J Reprod Contracept. 1997, 55:267-72. 10.1016\/s0010-7824(97)00029-2","journal-title":"Int J Reprod Contracept"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/s0010-7824(97)00118-2","article-title":"The use of oral contraceptives and the occurrence of acute myocardial infarction in young women","volume":"24","author":"Lewis MA","year":"2003","unstructured":"Lewis MA, Heinemann LA, Spitzer WO, et al.. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Europ Heart J. 2003, 24:377-80. 10.1016\/s0010-7824(97)00118-2","journal-title":"Europ Heart J"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(97)70168-6","article-title":"Modern oral contraceptives and cardiovascular disease","volume":"177","author":"Rosenberg L","year":"1997","unstructured":"Rosenberg L, Palmer JR, Sands MI, et al.. Modern oral contraceptives and cardiovascular disease. Am J Obstet Gynecol. 1997, 177:707-15. 10.1016\/S0002-9378(97)70168-6","journal-title":"Am J Obstet Gynecol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/189308-the-relationship-between-myocardial-infarction-and-estrogen-use-a-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:25Z","timestamp":1707509365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/189308-the-relationship-between-myocardial-infarction-and-estrogen-use-a-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.46134","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,28]]}}}